annual cash & cash equivalents:
$122.72M-$14.56M(-10.61%)Summary
- As of today (August 25, 2025), ATRC annual cash & cash equivalents is $122.72 million, with the most recent change of -$14.56 million (-10.61%) on December 31, 2024.
- During the last 3 years, ATRC annual cash & cash equivalents has risen by +$3.63 million (+3.05%).
- ATRC annual cash & cash equivalents is now -49.75% below its all-time high of $244.22 million, reached on December 31, 2020.
Performance
ATRC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$117.80M+$17.91M(+17.93%)Summary
- As of today (August 25, 2025), ATRC quarterly cash & cash equivalents is $117.80 million, with the most recent change of +$17.91 million (+17.93%) on June 30, 2025.
- Over the past year, ATRC quarterly cash & cash equivalents has increased by +$3.78 million (+3.31%).
- ATRC quarterly cash & cash equivalents is now -51.77% below its all-time high of $244.22 million, reached on December 31, 2020.
Performance
ATRC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATRC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | +3.3% |
| 3 y3 years | +3.0% | -0.6% |
| 5 y5 years | +50.0% | -49.3% |
ATRC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +3.0% | -14.2% | +17.9% |
| 5 y | 5-year | -49.8% | +50.0% | -51.8% | +17.9% |
| alltime | all time | -49.8% | +2271.3% | -51.8% | >+9999.0% |
ATRC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $117.80M(+17.9%) |
| Mar 2025 | - | $99.89M(-18.6%) |
| Dec 2024 | $122.72M(-10.6%) | $122.72M(-5.8%) |
| Sep 2024 | - | $130.34M(+14.3%) |
| Jun 2024 | - | $114.02M(+7.6%) |
| Mar 2024 | - | $105.96M(-22.8%) |
| Dec 2023 | $137.28M(+13.4%) | $137.28M(+3.2%) |
| Sep 2023 | - | $133.01M(+4.7%) |
| Jun 2023 | - | $127.03M(-6.5%) |
| Mar 2023 | - | $135.86M(+12.2%) |
| Dec 2022 | $121.11M(+1.7%) | $121.11M(-1.2%) |
| Sep 2022 | - | $122.64M(+3.5%) |
| Jun 2022 | - | $118.45M(+6.3%) |
| Mar 2022 | - | $111.40M(-6.5%) |
| Dec 2021 | $119.09M(-51.2%) | $119.09M(-0.5%) |
| Sep 2021 | - | $119.75M(-25.1%) |
| Jun 2021 | - | $159.87M(-29.6%) |
| Mar 2021 | - | $227.21M(-7.0%) |
| Dec 2020 | $244.22M(+198.6%) | $244.22M(+4.8%) |
| Sep 2020 | - | $233.07M(+0.2%) |
| Jun 2020 | - | $232.50M(+239.2%) |
| Mar 2020 | - | $68.54M(-16.2%) |
| Dec 2019 | $81.80M(-34.2%) | $81.80M(+2.6%) |
| Sep 2019 | - | $79.74M(-12.2%) |
| Jun 2019 | - | $90.84M(-9.7%) |
| Mar 2019 | - | $100.63M(-19.1%) |
| Dec 2018 | $124.40M(+261.1%) | $124.40M(+209.3%) |
| Sep 2018 | - | $40.22M(+8.5%) |
| Jun 2018 | - | $37.07M(+2.9%) |
| Mar 2018 | - | $36.04M(+4.6%) |
| Dec 2017 | $34.45M(-21.7%) | $34.45M(+0.2%) |
| Sep 2017 | - | $34.39M(-1.7%) |
| Jun 2017 | - | $34.98M(+1.5%) |
| Mar 2017 | - | $34.47M(-21.7%) |
| Dec 2016 | $44.01M(+27.3%) | $44.01M(+6.4%) |
| Sep 2016 | - | $41.34M(-2.6%) |
| Jun 2016 | - | $42.43M(+81.9%) |
| Mar 2016 | - | $23.32M(-32.5%) |
| Dec 2015 | $34.58M | $34.58M(-28.6%) |
| Sep 2015 | - | $48.43M(-11.1%) |
| Jun 2015 | - | $54.48M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $55.73M(-6.6%) |
| Dec 2014 | $59.65M(+127.6%) | $59.65M(+0.4%) |
| Sep 2014 | - | $59.43M(-6.0%) |
| Jun 2014 | - | $63.20M(-20.4%) |
| Mar 2014 | - | $79.36M(+202.8%) |
| Dec 2013 | $26.21M(+118.4%) | $26.21M(-11.7%) |
| Sep 2013 | - | $29.68M(-15.0%) |
| Jun 2013 | - | $34.94M(-3.0%) |
| Mar 2013 | - | $36.03M(+200.2%) |
| Dec 2012 | $12.00M(-15.4%) | $12.00M(-8.0%) |
| Sep 2012 | - | $13.05M(-3.0%) |
| Jun 2012 | - | $13.46M(-12.0%) |
| Mar 2012 | - | $15.29M(+7.8%) |
| Dec 2011 | $14.18M(+12.8%) | $14.18M(-6.8%) |
| Sep 2011 | - | $15.22M(-4.3%) |
| Jun 2011 | - | $15.91M(+1.6%) |
| Mar 2011 | - | $15.66M(+24.6%) |
| Dec 2010 | $12.57M(-20.0%) | $12.57M(+9.7%) |
| Sep 2010 | - | $11.46M(-4.4%) |
| Jun 2010 | - | $11.98M(+1.1%) |
| Mar 2010 | - | $11.84M(-24.7%) |
| Dec 2009 | $15.72M(-21.4%) | $15.72M(+2.9%) |
| Sep 2009 | - | $15.29M(-2.9%) |
| Jun 2009 | - | $15.74M(+82.8%) |
| Mar 2009 | - | $8.61M(-29.9%) |
| Sep 2008 | - | $12.28M(+3.0%) |
| Jun 2008 | - | $11.92M(-20.1%) |
| Mar 2008 | - | $14.92M(-25.4%) |
| Dec 2007 | $20.01M(+2.7%) | $20.01M(-5.7%) |
| Sep 2007 | - | $21.21M(-26.2%) |
| Jun 2007 | - | $28.74M(+79.8%) |
| Mar 2007 | - | $15.98M(-18.0%) |
| Dec 2006 | $19.49M(-42.3%) | $19.49M(-0.1%) |
| Sep 2006 | - | $19.51M(-21.9%) |
| Jun 2006 | - | $24.99M(-10.7%) |
| Mar 2006 | - | $27.98M(-17.2%) |
| Dec 2005 | $33.80M(+553.2%) | $33.80M(-11.8%) |
| Sep 2005 | - | $38.34M(+3414.8%) |
| Jun 2005 | - | $1.09M(-55.5%) |
| Mar 2005 | - | $2.45M(-52.6%) |
| Dec 2004 | $5.18M | $5.18M |
FAQ
- What is AtriCure, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AtriCure, Inc.?
- What is AtriCure, Inc. annual cash & cash equivalents year-on-year change?
- What is AtriCure, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for AtriCure, Inc.?
- What is AtriCure, Inc. quarterly cash & cash equivalents year-on-year change?
What is AtriCure, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ATRC is $122.72M
What is the all time high annual cash & cash equivalents for AtriCure, Inc.?
AtriCure, Inc. all-time high annual cash & cash equivalents is $244.22M
What is AtriCure, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ATRC annual cash & cash equivalents has changed by -$14.56M (-10.61%)
What is AtriCure, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ATRC is $117.80M
What is the all time high quarterly cash & cash equivalents for AtriCure, Inc.?
AtriCure, Inc. all-time high quarterly cash & cash equivalents is $244.22M
What is AtriCure, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ATRC quarterly cash & cash equivalents has changed by +$3.78M (+3.31%)